Rotana Alsaggaf

418 total citations
18 papers, 276 citations indexed

About

Rotana Alsaggaf is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Rotana Alsaggaf has authored 18 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 6 papers in Neurology. Recurrent topics in Rotana Alsaggaf's work include Genetic Neurodegenerative Diseases (9 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Telomeres, Telomerase, and Senescence (5 papers). Rotana Alsaggaf is often cited by papers focused on Genetic Neurodegenerative Diseases (9 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Telomeres, Telomerase, and Senescence (5 papers). Rotana Alsaggaf collaborates with scholars based in United States, United Kingdom and Canada. Rotana Alsaggaf's co-authors include Shahinaz M. Gadalla, Sharon A. Savage, Youjin Wang, Mark H. Greene, Belynda Hicks, Casey Dagnall, Marena R. Niewisch, Neelam Giri, Ruth M. Pfeiffer and Lisa J. McReynolds and has published in prestigious journals such as Blood, Gut and International Journal of Cancer.

In The Last Decade

Rotana Alsaggaf

18 papers receiving 275 citations

Peers

Rotana Alsaggaf
Rakesh K. Goyal United States
R. Lorenz Germany
Ping Ye United States
Joshua Paré United States
Rakesh K. Goyal United States
Rotana Alsaggaf
Citations per year, relative to Rotana Alsaggaf Rotana Alsaggaf (= 1×) peers Rakesh K. Goyal

Countries citing papers authored by Rotana Alsaggaf

Since Specialization
Citations

This map shows the geographic impact of Rotana Alsaggaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rotana Alsaggaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rotana Alsaggaf more than expected).

Fields of papers citing papers by Rotana Alsaggaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rotana Alsaggaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rotana Alsaggaf. The network helps show where Rotana Alsaggaf may publish in the future.

Co-authorship network of co-authors of Rotana Alsaggaf

This figure shows the co-authorship network connecting the top 25 collaborators of Rotana Alsaggaf. A scholar is included among the top collaborators of Rotana Alsaggaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rotana Alsaggaf. Rotana Alsaggaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gadalla, Shahinaz M., Timothy S. McNeel, William Wheeler, et al.. (2025). Spectrum of Cancers and Their Prognosis Among Patients With Myotonic Dystrophy. JAMA Network Open. 8(8). e2526894–e2526894. 1 indexed citations
2.
Alsaggaf, Rotana, Ruth M. Pfeiffer, Emily Pearce, et al.. (2024). Mortality Trends and Causes of Death in Myotonic Dystrophy Type 1 Patients From the UK Clinical Practice Research Datalink. Muscle & Nerve. 71(2). 229–236. 2 indexed citations
3.
Pearce, Emily, Rotana Alsaggaf, Shilpa Katta, et al.. (2022). Telomere length and epigenetic clocks as markers of cellular aging: a comparative study. GeroScience. 44(3). 1861–1869. 35 indexed citations
4.
Alsaggaf, Rotana, Shilpa Katta, Tao Wang, et al.. (2021). Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia. Transplantation and Cellular Therapy. 27(4). 313.e1–313.e8. 9 indexed citations
5.
Niewisch, Marena R., Neelam Giri, Lisa J. McReynolds, et al.. (2021). Disease progression and clinical outcomes in telomere biology disorders. Blood. 139(12). 1807–1819. 53 indexed citations
6.
Pearce, Emily, Steve Horvath, Shilpa Katta, et al.. (2021). DNA-methylation-based telomere length estimator: comparisons with measurements from flow FISH and qPCR. Aging. 13(11). 14675–14686. 22 indexed citations
7.
Alsaggaf, Rotana, Ruth M. Pfeiffer, Youjin Wang, et al.. (2019). Diabetes, metformin and cancer risk in myotonic dystrophy type I. International Journal of Cancer. 147(3). 785–792. 11 indexed citations
8.
Higgs, Cecilia, James E. Hilbert, Libby Wood, et al.. (2019). Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries. Frontiers in Neurology. 10. 1071–1071. 2 indexed citations
9.
Wang, Youjin, Ana F. Best, Roberto Fernández‐Torrón, et al.. (2019). Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study. Annals of Clinical and Translational Neurology. 7(1). 126–131. 5 indexed citations
10.
Alsaggaf, Rotana, Diane Marie M. St. George, Min Zhan, et al.. (2019). Benign tumors in myotonic dystrophy type I target disease‐related cancer sites. Annals of Clinical and Translational Neurology. 6(8). 1510–1518. 13 indexed citations
11.
Liu, Zhiwei, Rotana Alsaggaf, Katherine A. McGlynn, et al.. (2018). Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut. 68(8). 1458–1464. 27 indexed citations
12.
Alsaggaf, Rotana, Lyndsay M. O’Hara, Kristen A. Stafford, Surbhi Leekha, & Anthony D. Harris. (2018). Quasi-experimental Studies in the Fields of Infection Control and Antibiotic Resistance, Ten Years Later: A Systematic Review. Infection Control and Hospital Epidemiology. 39(2). 170–176. 6 indexed citations
13.
Liu, Zhiwei, Rotana Alsaggaf, Katherine A. McGlynn, et al.. (2018). Statin Use and Reduced Risk of Biliary Tract Cancers in the United Kingdom Clinical Practice Research Datalink. SSRN Electronic Journal. 1 indexed citations
14.
Wang, Youjin, Sharon A. Savage, Rotana Alsaggaf, et al.. (2018). Telomere Length Calibration from qPCR Measurement: Limitations of Current Method. Cells. 7(11). 183–183. 21 indexed citations
15.
Alsaggaf, Rotana, Diane Marie M. St. George, Min Zhan, et al.. (2018). Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity. JNCI Cancer Spectrum. 2(4). pky052–pky052. 23 indexed citations
16.
Wang, Youjin, Ruth M. Pfeiffer, Rotana Alsaggaf, et al.. (2017). Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. International Journal of Cancer. 142(6). 1174–1181. 30 indexed citations
17.
Alsaggaf, Rotana, Youjin Wang, Libby Wood, et al.. (2017). Benign and malignant tumors in the UK myotonic dystrophy patient registry. Muscle & Nerve. 57(2). 316–320. 13 indexed citations
18.
Zwenger, Sam R., Rotana Alsaggaf, & Chhandak Basu. (2010). Does an expressed sequence tag (EST) library ofSalsola iberica(tumbleweed) help to understand plant responses to environmental stresses?. Plant Signaling & Behavior. 5(11). 1330–1335. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026